Moira Garraus

484 total citations
13 papers, 154 citations indexed

About

Moira Garraus is a scholar working on Neurology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Moira Garraus has authored 13 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Moira Garraus's work include Neuroblastoma Research and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Lung Cancer Research Studies (4 papers). Moira Garraus is often cited by papers focused on Neuroblastoma Research and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Lung Cancer Research Studies (4 papers). Moira Garraus collaborates with scholars based in Spain, Canada and United States. Moira Garraus's co-authors include Jaume Mora, Mariona Suñol, Ignasi Barber, Emilio J. Inarejos Clemente, Ferrán Torner, Vicente Santa‐María, María Navallas, Sara Pérez‐Jaume, Oscar M. Navarro and Juan Pablo Muñoz and has published in prestigious journals such as Journal of Clinical Oncology, Radiographics and Frontiers in Pharmacology.

In The Last Decade

Moira Garraus

12 papers receiving 150 citations

Peers

Moira Garraus

NEURO

ONCOL

PRM

Valérie Bernier‐Chastagner France

Sho Kurihara Japan

Sara Pérez‐Jaume Spain

Luis Gros Spain

Karen S. Fernández United States

Agnieszka Mizia‐Malarz Poland

Fumito Yamazaki Japan

Alice Bonneville-Levard France

Stuart Cramer United States

Karishma Vijay Rupani United States

Valérie Bernier‐Chastagner France

Moira Garraus

64 ×0.7

NEURO

33 ×0.6

ONCOL

74 ×1.8

PRM

40 ×1.0

14 ×0.4

Citations per year, relative to Moira Garraus Moira Garraus (= 1×) peers Valérie Bernier‐Chastagner

Countries citing papers authored by Moira Garraus

Since Specialization

Citations

This map shows the geographic impact of Moira Garraus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moira Garraus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moira Garraus more than expected).

Fields of papers citing papers by Moira Garraus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moira Garraus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moira Garraus. The network helps show where Moira Garraus may publish in the future.

Co-authorship network of co-authors of Moira Garraus

This figure shows the co-authorship network connecting the top 25 collaborators of Moira Garraus. A scholar is included among the top collaborators of Moira Garraus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moira Garraus. Moira Garraus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Muñoz, Juan Pablo, Sara Pérez‐Jaume, Moira Garraus, et al.. (2024). Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy. Cancers. 16(9). 1735–1735. 1 indexed citations

Ramos, Mónica, et al.. (2024). Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes. Pediatric Blood & Cancer. 71(10). e31221–e31221. 1 indexed citations

Muñoz, Juan P., et al.. (2024). Naxitamab chemo-immunotherapy regimens other than with irinotecan/temozolomide for patients with relapsed/refractory high-risk neuroblastoma.. Journal of Clinical Oncology. 42(16_suppl). 10037–10037.

Muñoz, Juan Pablo, et al.. (2023). Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes. Cancers. 15(19). 4837–4837. 13 indexed citations

Mora, Jaume, Sara Pérez‐Jaume, Moira Garraus, et al.. (2023). Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use—Updated Outcome Report. Cancers. 15(9). 2535–2535. 11 indexed citations

Torner, Ferrán, et al.. (2022). Total calcaneal allograft reconstruction of an Ewing's sarcoma in a child: Outcome and review of the literature. Cancer Reports. 5(9). e1626–e1626. 5 indexed citations

Clemente, Emilio J. Inarejos, Oscar M. Navarro, María Navallas, et al.. (2022). Multiparametric MRI evaluation of bone sarcomas in children. Insights into Imaging. 13(1). 33–33. 14 indexed citations

Garraus, Moira, et al.. (2022). How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain. ESMO Open. 7(2). 100462–100462. 12 indexed citations

Mora, Jaume, et al.. (2021). Naxitamab combined with granulocyte‐macrophage colony‐stimulating factor as consolidation for high‐risk neuroblastoma patients in complete remission. Pediatric Blood & Cancer. 68(10). e29121–e29121. 22 indexed citations

10.

Mora, Jaume, Fernando Gómez, Vicente Santa‐María, et al.. (2021). Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma. Cancers. 13(6). 1264–1264. 9 indexed citations

11.

Clemente, Emilio J. Inarejos, María Navallas, Ignasi Barber, et al.. (2020). MRI of Rhabdomyosarcoma and Other Soft-Tissue Sarcomas in Children. Radiographics. 40(3). 791–814. 43 indexed citations

12.

Mora, Jaume, et al.. (2020). The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies. Frontiers in Pharmacology. 11. 575009–575009. 16 indexed citations

13.

Mora, Jaume, Brian H. Kushner, Vicente Santa‐María, et al.. (2019). Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study.. Journal of Clinical Oncology. 37(15_suppl). 10025–10025. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact